1. Home
  2. ULS vs ALGN Comparison

ULS vs ALGN Comparison

Compare ULS & ALGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo UL Solutions Inc.

ULS

UL Solutions Inc.

HOLD

Current Price

$76.59

Market Cap

15.4B

Sector

N/A

ML Signal

HOLD

Logo Align Technology Inc.

ALGN

Align Technology Inc.

HOLD

Current Price

$157.28

Market Cap

10.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ULS
ALGN
Founded
1894
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.4B
10.2B
IPO Year
2024
N/A

Fundamental Metrics

Financial Performance
Metric
ULS
ALGN
Price
$76.59
$157.28
Analyst Decision
Hold
Buy
Analyst Count
8
13
Target Price
$78.75
$190.50
AVG Volume (30 Days)
1.1M
1.6M
Earning Date
11-04-2025
10-29-2025
Dividend Yield
0.68%
N/A
EPS Growth
10.58
N/A
EPS
1.67
5.16
Revenue
$3,003,000,000.00
$3,982,622,000.00
Revenue This Year
$7.18
$2.58
Revenue Next Year
$5.56
$3.41
P/E Ratio
$45.86
$30.45
Revenue Growth
6.68
0.56
52 Week Low
$48.54
$122.00
52 Week High
$91.95
$246.19

Technical Indicators

Market Signals
Indicator
ULS
ALGN
Relative Strength Index (RSI) 34.51 73.38
Support Level $76.05 $144.00
Resistance Level $91.66 $152.99
Average True Range (ATR) 2.52 4.97
MACD -1.72 1.74
Stochastic Oscillator 3.46 92.40

Price Performance

Historical Comparison
ULS
ALGN

About ULS UL Solutions Inc.

UL Solutions is a global leader specializing in a broad range of product testing, inspection, and certification services. UL Solutions is the for-profit branch out of three organizations under the UL Enterprise. TIC operations make up nearly all of UL Solutions' total revenue and are composed of two segments: industrial and consumer. UL Solutions' remaining business includes software and advisory, which complements its core TIC offerings. The firm operates globally.

About ALGN Align Technology Inc.

Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.

Share on Social Networks: